LAURA BAKER: Open Payments
NPI 1417213729 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,447 in 85 payments from 16 companies in 2025. Trend: 2023 $1,456 · 2024 $1,078 · 2025 $1,447
Food & beverage: $1,362Education: $85
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 15 | $289 |
| Janssen Biotech, Inc. | 20 | $254 |
| ABBVIE INC. | 20 | $221 |
| LEO Pharma Inc. | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Mallinckrodt Hospital Products Inc. | 3 | $86 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| GENZYME CORPORATION | 4 | $72 |
| Organon LLC | 3 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
Products named: Bimzelx, TREMFYA, SKYRIZI, DUPIXENT, ACTHAR, ADBRY, ANZUPGO, VTAMA.
Industry payments across IN — which companies pay providers there.
